| When | Apr 29, 2021 from 10:30 AM to 06:20 PM |
|---|---|
| Where | Online via Zoom |
| Contact Name | Vicky Reid |
| Attendees | 140 |
| Add event to calendar |  vCal iCal |
THURSDAY 29 APRIL 2021
PLEASE REGISTER ON EVENTBRITE TO ENSURE YOU RECEIVE THE EVENT LINK NEAR THE TIME
REGISTRATION ON EVENTBRITE
10.30- 11.30 Abstracts open and poster presentations
12.00 – 12.10 Martin Bennett – Overview and progress of the CRE
SESSION 1 Population and Data Science (Chair John Danesh)
12.10 – 12.25 Emanuele Di Angelantonio, Cardiovascular disease risk prediction using UK Biobank TBC
12.25– 12.40 Lisa Pennells, New developments in Cardiovascular disease risk scores
12.40 – 12.55 Praveen Surendran, Genetic study molecular phenotypes to understand complex disease aetiology
SESSION 2 Functional Genomics (Chair Nicole Soranzo)
13.00 – 13.15 Seamus Harrison, Genomics of aortic diseases
13.15 – 13.30 Stefan Graf, Update on PAH genomics
13.30 – 13.45 Alex Granata, Modelling stroke using iPSCs
SESSION 3 Cardiometabolic Medicine (Chair Toni Vidal-Puig)
13.50 – 14.05 Julia Carrasco Zanini Sanchez, Studying the human plasma proteome at scale: from genes to disease
14.05 – 14.20 Dino Giussani, Heart Disease Link to Fetal Hypoxia
14.20 – 14.35 Ana Vujic, Benefits of Physical Exercise on the Aging heart
14.40-15.00 Break, Refreshments
SESSION 4 Cardiovascular Medicine (Chair Ziad Mallat)
15.00 – 15.15 Jordi Lambert, Heterogeneity in vascular smooth muscle cell activation.
15.15 – 15.30 Xuan Li, Microtubule-dependent mechanism in controlling cardiomyocyte contractility after myocardial infarction
15.30 – 15.45 Maria Colzani– Cardiovascular involvement in COVID-19
SESSION FIVE Translation (Chair Ian Wilkinson)
15.50 – 16.05 Tian Zhao, Interleukin-2 in ischaemic heart disease: the use of scRNA-seq in drug development
16.05 – 16.20 James Goodman, Cardiovascular Effects of GLP-1 and Glucagon Receptor Dual Agonism – New Insights
16.20 – 16.35 Li-ming Gan (AstraZeneca, Bioscience Cardiovascular) Microvascular inflammation in HFpEF
16.40– 17.20 Keynote speaker: Professor Aroon Hingorani (University College London), Democratising cardiovascular drug development through human genomics
17.20 – 17.30 Closing words and abstract/poster prizes- Martin Bennett
17.30 – 18.30 Networking session in breakout rooms
Document
